Wake Forest University
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Wake Forest University sits in the top decile of US sponsors by registered trial count (#240 of 15,742 sponsors by registered trial count).
Wake Forest University: 100 sponsored US clinical trials, 7 recruiting.
Wake Forest University sponsors 100 registered US clinical trials on ClinicalTrials.gov, 7 of them currently recruiting, and 74 completed. 22 of these trials are in Phase 3-4 (later-stage) and 15 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Urinary Incontinence, with 2 trials.
Top-decile sponsor footprint
Wake Forest University ranks in the top decile of sponsors by registered trial count (#240 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
74 of 92 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (80.4%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
100 total, page 2 of 2
A Comparison of Different Ventilation Strategies in Infants Using the PLMA™
NCT03235817
Early Provision of Enteral Microlipid and Fish Oil to Infants With Enterostomy
NCT01306838
Standardized Rehabilitation for Intensive Care Unit (ICU) Patients With Acute Respiratory Failure
NCT00976833
Physical and Cognitive Function - Look AHEAD Ancillary Study
NCT01410097
Tetracaine Combined Spinal Epidural (CSE) Versus Bupivacaine CSE
NCT01005459
Xience V at Wake Forest University Baptist Medical Center (WFUBMC)
NCT00937573
A Novel Method to Improve Acne Outcomes
NCT01176955
The Effect of Levocetirizine on Inflammatory Mediators in Dermatographism
NCT01008592
Adherence to Study Medication Compared to Generic Topical Clindamycin Plus Generic Topical Tretinoin in Subjects With Mild to Moderate Acne Vulgaris
NCT01047189
Pegaptanib Therapy in Non-Infectious Uveitic Cystoid Macular Edema
NCT00790803
Exercise Intolerance in Elderly Patients With Diastolic Heart Failure
NCT00959660
A 5 Year Follow-up on Newly Diagnosed Breast Cancer Patients
NCT01176838
Epidural Neostigmine for Labor Pain
NCT00779467
The Effects of Music Therapy on Women's Anxiety Before and During Cesarean Delivery
NCT01049477
Fixation of Unstable Distal Radius Fractures
NCT00654615
Long-Term One Year Use of Alefacept (Amevive®) in Moderate to Severe Chronic Plaque Type Psoriasis
NCT00655564
Measuring Adherence to Topical Therapy in Children With Atopic Dermatitis and the Impact of a Return Visit
NCT00654355
Effect of Spinal Ketorolac on Mechanical Hypersensitivity After a Total Hip Replacement
NCT00621530
Ethnic Differences in Response to Topical Capsaicin: A Psychophysical Study on Healthy Subjects
NCT00655811
Three Way Interaction Between Gabapentin, Duloxetine, and Donepezil in Patients With Diabetic Neuropathy
NCT00619983
Rhubarb and Angiotensin Converting Enzyme Inhibitor
NCT00672451
Effect of Spinal Ketorolac After Acute Opioid Exposure
NCT00693160
Efficacy of Desonide (Desonatetm) Gel 0.05% in Younger and Older Subjects With Atopic Dermatitis
NCT00690833
Severity Postoperative Pain Prediction
NCT00638404
Effect Of Acute Inflammatory Mediators On Functional Limitations In Patients With Acute Respiratory Failure
NCT01707303
Physical Activity Program for Older Renal Transplant Candidates
NCT00857974
Compatibility of a Mild, Moisturizing Hand Cleanser for Patients With Mild to Moderate Hand Dermatitis
NCT00843466
Evaluation of Scalp and Hair Shaft With Biologic Markers in African American and Caucasian Hair
NCT00690664
Measuring Adherence To Topical 5-Fluorouracil in a Clinic Population
NCT00696488
Structural Analysis of Human Tissue
NCT01293864
Comprehensive Investigation of Heart Rate Variability as a Measure of the Autonomic Nervous System in Atopic Dermatitis
NCT00691366
Adherence to Topical Hydrocortisone 17-butyrate 0.1% (Locoid®) Using Different Vehicles in Adults With Atopic Dermatitis
NCT00693693
Comparative Study of the Efficacy of SARNA Sensitive Lotion for Treatment of Uremic Itch in Adult Hemodialysis Patients
NCT00693654
Clinical Trial to Evaluate Biafine Cream Versus Standard Care in Subjects With Actinic Keratosis Post Cryotherapy
NCT00695578
Intensive Diet and Exercise for Improving Knee Osteoarthritis in Obese and Overweight Older Adults
NCT00381290
Measuring Adherence in Subjects With Acne Vulgaris in a Clinic Population Subtitle: Topical Benzoyl Peroxide for Acne
NCT00658112
Analysis of Adherence in Subjects Undergoing Differin Gel, 0.1% Treatment of Moderate to Severe Acne Vulgaris
NCT00696449
Effects of Capsaicin on the Structure, Distribution, and Function of Cutaneous Small Nerve Fibers in Psoriatic Skin
NCT00697034
Expression of Fas Protein in Skin Biopsies of Participants With Scarring Alopecia
NCT00691769
Comprehensive Investigation of Opiates, Neuropeptides, Barrier Function, Scratching and Sleep Physiology
NCT00696397
Benefits of Tanning in Fibromyalgia Patients
NCT00447083
PIE II: Pharmacological Intervention in the Elderly II
NCT00123955
Treatment of Nodular Basal Cell Carcinoma (BCC) With Imiquimod 5% Cream After Curettage
NCT00314756
Thalidomide in the Treatment of Chronic Plaque Psoriasis.
NCT01891019
Cognition in the Study of Tamoxifen and Raloxifene
NCT00687102
Macrolide Antibiotic Therapy for Patients With Cystic Fibrosis
NCT00205634
Women's Health Initiative Study of Cognitive Aging
NCT00631332
Study of Expectorant Activity of Oral N-acetylcystein (NAC) in Patients With Stable Chronic Bronchitis
NCT00205647
Post-hospitalization Nursing Effectiveness (PHONE) Study
NCT00314431
Prospective Aerobic Reconditioning Intervention Study
NCT01113840
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 5 |
| Phase 2 | 10 |
| Phase 3 | 3 |
| Phase 4 | 19 |
Therapeutic Areas
What is open in the Wake Forest University pipeline
7 recruiting of 100 indexed (7% open); 74 completed (74%).
Phase mix: 22 late (III/IV) vs 15 early (I/II) (balanced across stages).
Top condition: Urinary Incontinence (2 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Wake Forest University: open-pipeline peers nationwide
Peers matched on 100 registered trials and 7% open enrollment, not the therapeutic-area sidebar.
Wake Forest University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 100 trials (± recruiting share)
- UCB Pharma · 100 trials · 0% recruiting
- Spaulding Rehabilitation Hospital · 101 trials · 19% recruiting
- GE Healthcare · 99 trials · 8% recruiting
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C. · 102 trials · 0% recruiting
Sponsors near 7% open enrollment (± trial volume)
- H. Lundbeck A/S · 7% recruiting · 72 trials
- Genentech · 7% recruiting · 332 trials
- State University of New York - Upstate Medical University · 7% recruiting · 113 trials
- BioCryst Pharmaceuticals · 7% recruiting · 29 trials
Related
What to do with this Wake Forest University page
100 registered trials is a research-attention snapshot, not an endorsement of Wake Forest University or any single study.
- 7 of Wake Forest University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Urinary Incontinence is the condition Wake Forest University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Urinary Incontinence trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Wake Forest University pipeline card: 100 registered trials from official public datasets.Report a data error.